Poly Medicure share price
NSE: POLYMEDBSE: 531768Healthcare Equipment & SuppliesSmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,448.90.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹14,637 Cr425th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 7 Aug 2026
- 46.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 25 May 2026
- 4.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 7 Aug 2026
- 10.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 7 Aug 2026
- 9.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 86,15649.1% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 7 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹525 Crdown 1.71%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹85 Crup 31.11%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 16.2%
Revenue by year
Net profit by year, a loss in red
| ₹ crore | Sep 2024Filed 30 Oct | Dec 2024Filed 3 Feb | Mar 2025Filed 10 Jun | Jun 2025Filed 8 Aug | Sep 2025Filed 8 Nov | Dec 2025Filed 5 Feb | Mar 2026Filed 25 May | Jun 2026Filed 7 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 420 | 424 | 441 | 403 | 444 | 494 | 535 | 525 |
| Net profit | 87 | 85 | 92 | 93 | 92 | 71 | 65 | 85 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 20.8% | 20.1% | 20.8% | 23.1% | 20.7% | 14.3% | 12.2% | 16.2% |
Business segments
In the year to Mar 2026 the company reports one business segment, Manufacturing of Medical Devices, which carries all its revenue.
Valuation
Today, against the company's own history.PE ratio and valuation history
At or below today's level on 47% of 2,480 trading days over the last 10 years.
At or below today's level on 5% of 1,885 trading days since Nov 2018.
At or below today's level on 33% of 1,885 trading days since Nov 2018.
At or below today's level on 43% of 2,478 trading days over the last 10 years.
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −46.7% | −4.9% | −44.2% | 0.3% |
| 3 years | +7.9% | +19.4% | −9.8% | 0.2% |
| 5 years | +7.9% | +17.5% | −8.4% | 0.2% |
Mutual funds holding it
75 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 50 of the 54 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.Mutual fund holdings
- AddedAdded. Funds that held more shares than at the end of the month before.
- 19
- CutCut. Funds that held fewer shares than at the end of the month before.
- 35
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 21
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end.
- 1
| Fund | |||
|---|---|---|---|
 quant Small Cap Fundquant Mutual Fund | 43,57,016 | 2.05% | ₹729.3 Cr |
 UTI Flexi Cap FundUTI Mutual Fund | 13,63,413 | 1.01% | ₹228.2 Cr |
 HSBC Midcap FundHSBC Mutual Fund | 12,33,816 | 1.23% | ₹206.5 Cr |
 SBI Healthcare Opportunities FundSBI Mutual Fund | 6,40,000 | 1.82% | ₹107.1 Cr |
| SBI MNC FundSBI Mutual Fund | 5,60,000 | 1.47% | ₹93.7 Cr |
 WhiteOak Capital Flexi Cap FundWhiteOak Capital Mutual Fund | 2,76,291 | 0.50% | ₹46.2 Cr |
| quant Multi Cap Fundquant Mutual Fund | 2,64,798 | 0.59% | ₹44.3 Cr |
 Invesco India Large Cap FundInvesco Mutual Fund | 1,73,600 | 1.51% | ₹29.1 Cr |
| WhiteOak Capital Mid Cap FundWhiteOak Capital Mutual Fund | 1,55,414 | 0.35% | ₹26.0 Cr |
| WhiteOak Capital Multi Cap FundWhiteOak Capital Mutual Fund | 1,46,104 | 0.57% | ₹24.5 Cr |
Peers and competitors
Medical Equipment & Supplies, 27 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Poly Medicure in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Molbio DiagnosticsMOLBIO | 14,279 | – | – | – | – | – | – | – | 0.00% |
 Fischer Medical VenturesFISCHER | 1,738 | 58.1 | – | – | +196.0% | +354.6% | 8.3% | 10.2% | 0.20% |
 Tarsons ProductsTARSONS | 1,596 | 143.9 | 2.5 | 16.4 | +10.6% | −59.7% | 1.8% | 1.5% | 0.00% |
 Q-Line BiotechQLINE | 1,235 | 22.2 | – | – | – | – | 22.6% | – | 0.00% |
 Laxmi DentalLAXMIDENTL | 937 | 30.3 | 3.8 | 20.2 | – | – | 13.7% | 12.0% | 0.00% |
 Hemant Surgical IndustriesHSIL | 829 | 45.6 | – | – | +117.4% | +126.2% | 18.1% | – | 0.00% |
 Vasa DenticityDENTALKART | 794 | – | 4.6 | – | – | – | – | – | 0.00% |
 Osel DevicesOSELDEVICE | 605 | 20.7 | 3.0 | – | – | – | 14.3% | – | 0.29% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.| Ex-date | Type | Per share |
|---|---|---|
| 28 Aug 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹3.50 |
| 18 Sep 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹3.50 |
| 19 Sep 2024 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹3.00 |
| 21 Sep 2023 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹3.00 |
| 16 Sep 2022 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.50 |
| 16 Sep 2021 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.50 |
Latest announcements
Routine notices left out.Share news and announcements
Sep 2026
24 Sep · General Updates
Poly Medicure share price by year
Each calendar year to 2025.Poly Medicure share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 1,773.70 | −32.2% | 2,842.65 | 1,698.70 |
| 2024 | 2,615.25 | +75.5% | 3,128.90 | 1,390.55 |
| 2023 | 1,489.90 | +65.9% | 1,666.75 | 832.55 |
| 2022 | 897.85 | −6.3% | 1,031.35 | 667.75 |
| 2021 | 957.95 | +89.2% | 1,133.15 | 506.55 |
| 2020 | 506.20 | +132.1% | 536.25 | 202.85 |
| 2019 | 218.05 | −1.9% | 228.05 | 168.85 |
| 2018 | 222.20 | −20.4% | 290.00 | 191.15 |
| 2017 | 279.25 | +46.6% | 304.00 | 189.30 |
| 2016 | 190.45 | −4.5% | 215.28 | 124.28 |
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 1,441.70 | 1,455.80 | 1,403.20 | 1,444.00 | 1,430.43 | 86,156 | 49.1% |
| 22 Oct 2026 | 1,464.90 | 1,517.80 | 1,431.50 | 1,448.90 | 1,474.50 | 1,95,822 | 40.5% |
| 21 Oct 2026 | 1,545.00 | 1,554.00 | 1,455.10 | 1,470.10 | 1,477.73 | 1,97,058 | 68.6% |
| 19 Oct 2026 | 1,594.90 | 1,594.90 | 1,543.00 | 1,550.70 | 1,558.53 | 55,799 | 44.1% |
| 16 Oct 2026 | 1,578.80 | 1,601.10 | 1,575.10 | 1,593.80 | 1,593.35 | 45,455 | 49.4% |
| 15 Oct 2026 | 1,589.90 | 1,614.90 | 1,575.90 | 1,583.80 | 1,596.38 | 50,933 | 48.5% |
| 14 Oct 2026 | 1,600.00 | 1,608.40 | 1,575.50 | 1,589.30 | 1,595.12 | 68,558 | 59.9% |
| 13 Oct 2026 | 1,630.00 | 1,630.00 | 1,596.00 | 1,600.00 | 1,607.10 | 77,984 | 65.5% |
| 12 Oct 2026 | 1,599.00 | 1,649.90 | 1,582.10 | 1,641.20 | 1,620.49 | 54,472 | 41.5% |
| 9 Oct 2026 | 1,596.00 | 1,617.60 | 1,545.60 | 1,587.10 | 1,584.74 | 87,914 | 35.4% |
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Bonus shares and stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 24 Mar 2017 | Bonus | 0.5000 | Holders received 1 bonus share for every 1 held. |
| 2 Feb 2015 | Split | 0.5000 | Each share became 2. |
| 9 Jul 2013 | Bonus | 0.5000 | Holders received 1 bonus share for every 1 held. |
| 26 Mar 2010 | Price move | – | Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown. |
About Poly Medicure
Poly Medicure Limited manufactures and exports medical devices for use in hospitals, in areas such as infusion therapy, anaesthesia, oncology, urology and gastroenterology. Its products are exported to more than 125 countries, and in India they are supplied to more than 8,000 private and government hospitals and nursing homes.
The product range is organised in verticals: infusion therapy, oncology, anaesthesia and respiratory care, urology, gastroenterology, vascular access, surgery and wound drainage, dialysis and renal care, diagnostics, transfusion systems and veterinary devices. It entered cardiology in 2024. The company sells to Europe, Africa, the Americas, Australia and Asia through more than 1,000 distributors worldwide. It runs one research and development centre, at Faridabad in Haryana.
In India, its factories are in Faridabad in Haryana, in Jaipur in Rajasthan, where one unit is in a special economic zone, and in Haridwar in Uttarakhand. Abroad, it has facilities in China through its wholly owned subsidiary Poly Medicure Laiyang Company Limited, in Italy through its step-down subsidiary Plan1 Health s.r.l., and in Egypt through an associate, Ultra For Medical. A subsidiary, Polyhealth Ltd, was set up in England and Wales in the year to March 2025.
The company was established in 1995, and its registered office is in Okhla, New Delhi. It made its public share offer in 1996. It has acquired Citieffe. It describes itself as the first indigenous dialyzer manufacturer in India. Its managing director, Himanshu Baid, and joint managing director, Rishi Baid, lead the company and are first generation entrepreneurs.
Written from the annual report for the year to Mar 2025. A newer annual report was filed on 14 Aug 2026.
- Legal name
- Poly Medicure Limited
- NSE symbol
- POLYMED
- BSE code
- 531768
- ISIN
- INE205C01021
- Industry
- Healthcare Equipment & Supplies
- Listed
- Jun 1996 on BSE, Dec 2011 on NSE
- Face value
- ₹5
- CIN
- L40300DL1995PLC066923
- Corporate identity number, the registrar of companies' code for it